Obesity, Abdominal: Clinical Trials

10 trials for Obesity, Abdominal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 recruiting. 10 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 9, Recruiting 1
Phase 21Completed 1

Follow Obesity, Abdominal: new trials by email Literature Review of Obesity, Abdominal trials Research Report on Obesity, Abdominal

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Orforglipron, Placebo - Overweight, Prediabetic State
Phase 3RecruitingEli Lilly and Company20012026-08-262026-11-05
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
Liraglutide Pen Injector [Saxenda], Placebo Liraglutide Pen Injector - Pre Diabetes, Polycystic Ovary Syndrome
Phase 3CompletedWoman's882018-09-262021-06-07
Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management
LLLT, Lorcaserin - Overweight, Obese
Phase 3CompletedMayo Clinic442014-06-012016-11-22
Diet and Body Composition
Weight-loss diet strategy (+) exercise (PA), weight loss (-) exercise (PA) - Obesity
Phase 3CompletedBen-Gurion University of the Negev2242012-10-012020-10-23
Vitamin D and Omega-3 Inhibit Metabolic Syndrome
low glycemic diet, vitamin D omega-3 - Type 2 Diabetes Mellitus, Hypertension
Phase 3CompletedUniversity of Guelph402011-04-012013-06-13
Grain Exercise Trial - Whole Grain Versus no Grain With or Without Physiotherapy-promoted Exercise for Waist Loss
Diet A, Diet B, Physiotherapy - Abdominal Obesity, Cardiovascular Diseases
Phase 2 / Phase 3CompletedLund University1052010-08-012017-06-20
Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study)
Weight Loss Diets Plus Exercise - Overweight, Obese
Phase 3CompletedJohns Hopkins University772009-10-012013-04-04
The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients
Carvedilol CR + Lisinopril, Lisinopril + HCTZ - Abdominal Obesity, Hypertension
Phase 3CompletedSt. Paul Heart Clinic252007-04-012013-12-06
Rosuvastatin in Visceral Adiposity
Rosuvastatin, Placebo for rosuvastatin - Abdominal Obesity
Phase 3CompletedGöteborg University542006-05-012015-08-24
Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus
recombinant human growth hormone - Abdominal Obesity, Metabolic Syndrome
Phase 3CompletedGöteborg University401999-01-012008-10-29

Narrower conditions

Obesity (5)  ·  Overweight (5)  ·  Hypertension (3)  ·  Weight Loss (3)  ·  Diabetes Mellitus, Type 2 (2)  ·  Glucose Intolerance (2)  ·  Prediabetic State (2)  ·  Cardiovascular Diseases (1)  ·  Hyperlipidemias (1)  ·  Hypertriglyceridemia (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)  ·  Motor Activity (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Body Weight (10)  ·  Nutrition Disorders (10)  ·  Nutritional and Metabolic Diseases (10)  ·  Overnutrition (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (10)  ·  Glucose Metabolism Disorders (5)  ·  Metabolic Diseases (5)  ·  Obesity (5)  ·  Overweight (5)  ·  Diabetes Mellitus (4)  ·  Endocrine System Diseases (4)  ·  Vascular Diseases (4)  ·  Body Weight Changes (3)  ·  Cardiovascular Diseases (3)

Interventions

Exercise (3)  ·  Carvedilol (1)  ·  Diet, Reducing (1)  ·  Growth Hormone (1)  ·  Hydrochlorothiazide (1)  ·  Liraglutide (1)  ·  Lisinopril (1)  ·  Low-Level Light Therapy (1)  ·  Physical Therapy Modalities (1)  ·  Rosuvastatin Calcium (1)  ·  Whole Grains (1)  ·  lorcaserin (1)  ·  orforglipron (1)

Sponsors

Göteborg University (2)  ·  Ben-Gurion University of the Negev (1)  ·  Eli Lilly and Company (1)  ·  Johns Hopkins University (1)  ·  Lund University (1)  ·  Mayo Clinic (1)  ·  St. Paul Heart Clinic (1)  ·  University of Guelph (1)  ·  Woman's (1)

Countries

United States (5)  ·  Sweden (3)  ·  Argentina (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Germany (1)  ·  India (1)  ·  Israel (1)  ·  Japan (1)  ·  Mexico (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Aaron S Kelly, PhD (1)  ·  Anna Nilsson, MD, PhD (1)  ·  Claes Ohlsson, Professor (1)  ·  Ivana T. Croghan, PhD (1)  ·  John-Olov Jansson, Prof (1)  ·  Kelly A Meckling, PhD (1)  ·  Kerry J Stewart, EdD (1)  ·  Kristjan Karason, MD, PhD (1)  ·  Peggy Dean, PharmD (1)  ·  Staffan Lindeberg, MD PhD (1)

Results publications

PMID 27708788, PMID 28501343, PMID 28814394, PMID 29142011, PMID 29190720, PMID 29576369, PMID 31075323, PMID 33634382, PMID 33663610, PMID 33938135, PMID 34836081, PMID 35348584, PMID 35657082, PMID 35710599, PMID 38639002, PMID 39901232, PMID 40472282, PMID 41039470, PMID 41612310, PMID 42227111

NIH funding

R01HL092280 (1)